Nuvo Group
Nuvo Group (NASDAQ: NUVO) develops the FDA-cleared INVU wearable platform for remote, continuous fetal-maternal monitoring, serving OB/GYNs, maternal-fetal medicine specialists, and expectant mothers — particularly in maternity-care deserts — through a healthcare-provider subscription/lease model with EMR-integrated clinician tools.
- Company typePrivate
- Founded2007
- HeadquartersTel Aviv, Israel
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Nuvo Group does
Nuvo Group (NASDAQ: NUVO) is a digital health company headquartered in Tel Aviv, Israel with U.S. operations in Aventura, Florida. The company develops the INVU by Nuvo platform — a prescription-based, FDA-cleared (K210025) and CE-marked system comprising a wearable sensor band with multiple detachable sensors, a patient-facing mobile application (iOS/Android), a cloud-based data processing platform, and a clinician web portal (INVU Pro) with EMR integration via Nuvo-supplied APIs. The platform enables expectant mothers — particularly those with high-risk pregnancies or limited obstetric access — to conduct clinically validated non-stress tests and continuous fetal-maternal heart-rate monitoring at home, with data transmitted to healthcare providers for remote review.
The company's core technology captures native fetal and maternal ECG and phonocardiography alongside uterine activity through a novel cardiac-derived algorithm published in the American Journal of Obstetrics and Gynecology. Nuvo has accumulated what it describes as the largest real-world longitudinal dataset of synchronized maternal-fetal physiological signals (350,000+ minutes across 25,000+ sessions), IRB-approved for retrospective analysis, which underpins its AI roadmap for early-complication detection, predictive analytics, and population-health tools developed in partnership with Sheba Medical Center's ARC innovation arm.
Nuvo generates revenue primarily through a subscription/lease model in which healthcare providers lease the INVU monitoring kit and prescribe it to expectant mothers, with sessions billed through providers and payers. Go-to-market relies on enterprise field sales to OB/GYNs and maternal-fetal medicine specialists, channel partnerships with telehealth and virtual-hospital providers (Ouma Health, Sheba Beyond), and direct deployments into rural hospitals (Golden Valley Memorial Healthcare). A future revenue stream from data licensing of the AI-ready pregnancy dataset is contemplated but not yet commercialized. Customer segments span pregnant women (especially high-risk), healthcare providers, payers/employers, and rural health systems addressing maternity-care deserts.
Nuvo Group firmographics
Firmographics- Name
- Nuvo Group
- Legal name
- Nuvo Intl Group Inc.
- Website
- https://nuvocares.com
- Company type
- Private
- Founded year
- 2007
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Nuvo Group (NASDAQ: NUVO) develops the FDA-cleared INVU wearable platform for remote, continuous fetal-maternal monitoring, serving OB/GYNs, maternal-fetal medicine specialists, and expectant mothers — particularly in maternity-care deserts — through a healthcare-provider subscription/lease model with EMR-integrated clinician tools.
- Ownership category
- akta.pro rank
Nuvo Group industry classification
Industry- Product category
- Remote Pregnancy Monitoring
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)
- akta.pro secondary industries
- Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG), Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring) (HLALAHAC)
Keywords
Where Nuvo Group is headquartered
LocationHeadquarters
- HQ city
- Tel Aviv
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Nuvo Group business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Device Leasing: INVU monitoring kit is leased through healthcare providers. The wearable sensor band is provided to expectant mothers via prescription through their healthcare provider, with the provider leasing the system.
- Remote Monitoring Services: Revenue generated from remote fetal monitoring sessions conducted through the INVU platform, billed through healthcare providers and payers.
- Data Licensing (Future): Potential future revenue from the large-scale pregnancy dataset for research and AI development purposes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Healthcare provider leasing model |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels6 records
Nuvo Group product offering
Product offeringCore offering
Nuvo Group develops and sells the INVU by Nuvo platform, the first and only FDA-cleared wearable system for remote, continuous fetal-maternal monitoring. The platform consists of a proprietary sensor band worn around the expectant mother's belly, a patient-facing mobile app (iOS/Android), the INVU Pro clinician web portal, and a cloud-based data processing platform with EMR integration, enabling pregnant women to perform clinically validated non-stress tests at home or work while clinicians review the data remotely.
Product overview
Nuvo Group offers the INVU by Nuvo™ platform — a comprehensive remote pregnancy monitoring solution comprised of an FDA-cleared wearable sensor band, a patient-facing mobile app (available on iOS and Android), a clinician web portal (INVU Pro), and a proprietary cloud-based data processing platform. The system enables expectant mothers to perform clinically validated non-stress tests (NSTs) and fetal-maternal heart rate monitoring at home or work, with data transmitted to healthcare providers for review. Nuvo also offers an AI-ready longitudinal pregnancy dataset built from INVU monitoring sessions, and the INVU Pro clinician portal enables prescription management, session scheduling, EMR integration, and clinical data review. A recently launched RHTP Application Support Package helps rural providers pursue federal funding for INVU deployment.
Differentiator
Problem solved
Functional benefit
Brands
- INVU: FDA-cleared remote pregnancy monitoring wearable platform with sensor band, mobile app, and cloud-based data capture and visualization for fetal and maternal health monitoring.
- INVU Pro
Products and services
- INVU Wearable Sensor Band FDA-cleared wearable sensor band worn around the expectant mother's belly that captures fetal ECG, fetal phonocardiography, maternal ECG, maternal phonocardiography, and uterine activity data during remote monitoring sessions; provided to expectant mothers via prescription through healthcare providers.
- INVU Mobile App Patient-facing iOS and Android mobile application that connects to the INVU sensor band via Bluetooth, guides self-administered monitoring sessions, delivers self-guided training, allows patients to chat with support, and access monitoring results and session data.
- INVU Pro Clinician Portal Web-based portal for healthcare providers to prescribe the INVU system, schedule remote monitoring sessions, review and interpret monitoring data transmitted from patient devices, and integrate session data into the provider's EMR.
- INVU Cloud Platform Proprietary cloud-based platform that captures, analyzes, and transmits patient data from the INVU sensor band, supports the monitoring workflow for patients and clinicians, stores physiological data in a data lake, and enables integration with EMR systems via Nuvo-supplied APIs.
- INVU AI-Ready Pregnancy Dataset Large-scale real-world longitudinal dataset of synchronized maternal and fetal physiological signals built from INVU monitoring sessions, combining fetal ECG and phonocardiography with maternal ECG and phonocardiography collected in clinical and home settings; IRB-approved for retrospective analyses and AI model training.
Quantifiable outcome
- One patient maintained pregnancy from week 32 to week 37 when doctors expected induction at week 34, using remote monitoring instead of hospital admission
- +2 more outcomes
Companies that use Nuvo Group
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles3 records
Nuvo Group technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
AI capability7 records
Feature5 records
Nuvo Group partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and strategic.
- TLC PerinatalcoreTLC Perinatal, a leading maternal-fetal medicine practice in the DC-Maryland region, adopted INVU for on-demand fetal monitoring. The practice provides pregnant women access to remote non-stress tests connected with their healthcare team for clinical review, supporting high-risk and proactive care.
- Golden Valley Memorial Healthcare (GVMH)strategicGolden Valley Memorial Healthcare deployed INVU to improve maternal health in rural Missouri, addressing the challenge of limited access to obstetric care in maternity care deserts. GVMH is one of the first regional hospitals to deploy this technology to enhance prenatal care for high-risk pregnancies.
- PhilipsstrategicPhilips teams up with Nuvo to broaden maternity care access in rural areas with remote monitoring technology, combining Philips' healthcare technology portfolio with Nuvo's INVU platform.
- MFM AssociatescoreNuvo partnered with MFM Associates to offer remote Non-Stress Tests (NSTs) in New York City, expanding access to INVU monitoring through maternal-fetal medicine specialists.
- ARC (Sheba Medical Center's Innovation Arm)coreARC and Nuvo are developing advanced AI-driven solutions that enhance clinical decision-making, improve early detection of pregnancy complications, and redefine continuous pregnancy monitoring. The collaboration will create AI-based modules for clinical decision-support tools and population health analysis to improve prenatal care quality.
- Georgia State UniversitystrategicNuvo partnered with Georgia State University for an NIH-funded multisite study titled 'Advancing understanding of racism-related health disparities beginning before birth.' The study utilizes INVU to research how racism-related stressors impact maternal and fetal health among 400 Black and Latina women in their third trimester.
- Sheba Medical Center / Sheba BeyondcoreNuvo partnered with Sheba Beyond, one of the world's first virtual hospitals, to transform care for high-risk pregnant patients. The partnership accelerated during wartime Israel to de-hospitalize high-risk inpatients while maintaining exceptional care. Sheba Beyond has been utilizing INVU for over a year to monitor pregnant patients remotely, with benefits including clinical accuracy, resource optimization, and improved patient outcomes.
- Ouma HealthcoreNuvo and Ouma partnered to deliver the world's first telehealth and remote monitoring solution for pregnancy care. The joint solution combines Ouma's 24/7/365 maternity telehealth clinical services with INVU's FDA-cleared remote fetal surveillance technology to provide equitable access to care, improve preventative care delivery, and reduce costs.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Nuvo Group competitors and assessment
Company assessmentDirect peers
- Bloomlife: Bloomlife develops pregnancy-monitoring wearables that capture uterine and fetal signals for remote, at-home use. It is the closest direct competitor to Nuvo's INVU in the remote fetal-maternal wearable category.
- HeraMED: HeraMED builds FDA-cleared remote fetal monitoring and pregnancy care solutions including the HeraBEAT handheld Doppler and SaaS maternal health platform. It competes directly with INVU in remote NST and home maternal monitoring.
Broad incumbents
- Philips: Philips is a global incumbent in maternal-fetal monitoring (e.g., Avalon fetal monitors) and is also an INVU distribution partner. It competes with Nuvo in clinical fetal monitoring and could expand its own wearable roadmap.
- GE HealthCare: GE HealthCare sells the Giraffe and Corometrics lines of fetal monitors used in hospitals and OB/MFM practices worldwide. It is a broad incumbent serving the same buyer base as INVU with established inpatient monitoring.
- Mindray: Mindray is a global medical device incumbent with a substantial patient and fetal monitoring portfolio sold into hospitals. It competes with Nuvo at the hospital procurement level even though it does not focus on remote at-home NST.
Emerging players
- Owlet: Owlet offers FDA-cleared baby monitors (e.g., Dream Sock) that track infant vital signs. While focused on the infant post-birth segment, Owlet competes for the same expectant-parent attention and connected-care wallet.
- Babyscripts: Babyscripts provides a digital maternity care platform combining remote patient monitoring, education, and risk stratification for payers and providers. It overlaps with Nuvo in the digital maternal RPM space, though its hardware is more limited.
- Maven Clinic: Maven Clinic operates the largest virtual clinic for women's and family health, offering maternity care programs for employers and payers. It is a partial competitor via telehealth, especially through its overlap with Ouma Health.
Others
- Oura: Oura sells a consumer smart ring for continuous physiological monitoring (temperature, HR, sleep). It is thematically adjacent as a wearable health-data platform but does not currently monitor fetal signals or compete with INVU clinically.
- iHealth Labs: iHealth Labs produces connected consumer health devices (BP monitors, glucose meters, thermometers) sold via retail and pharmacy channels. It is an adjacent connected-health hardware player but not a clinical fetal monitoring competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Nuvo Group social profiles
Digital presenceNuvo Group compliance and trust
Trust signalCompliance4 records
Nuvo Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nuvo Group leadership team
Management profileNumber of profiles
Profiles8 records
Nuvo Group funding detail
Funding detailFunding overview
Funding rounds4 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nuvo Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nuvo Group
What does Nuvo Group do?
Nuvo Group develops and sells the INVU by Nuvo platform, the first and only FDA-cleared wearable system for remote, continuous fetal-maternal monitoring. The platform consists of a proprietary sensor band worn around the expectant mother's belly, a patient-facing mobile app (iOS/Android), the INVU Pro clinician web portal, and a cloud-based data processing platform with EMR integration, enabling pregnant women to perform clinically validated non-stress tests at home or work while clinicians review the data remotely.
Is Nuvo Group a public or private company?
Nuvo Group is a private company. It is classified as public and is currently operating.
When was Nuvo Group founded?
Nuvo Group was founded in 2007. It employs 51 to 100 people.
Where is Nuvo Group based?
Nuvo Group is headquartered in Tel Aviv, Israel, in the Middle East region.
How does Nuvo Group make money?
Three revenue lines are on record. Device Leasing is the primary driver. The others are remote Monitoring Services and data Licensing (Future).
Who are Nuvo Group's main competitors?
Direct peers on record are Bloomlife and HeraMED. Broad incumbents are Philips, GE HealthCare and Mindray. Emerging players are Owlet, Babyscripts and Maven Clinic. Others are Oura and iHealth Labs.
Does Nuvo Group have an API?
Yes. Nuvo allows healthcare providers to connect their Electronic Medical Records (EMR) to the INVU System through one or more APIs supplied by Nuvo. The privacy policy states: 'If you're a Provider, we allow you to connect your electronic medical records ("EMR") to the INVU System through the use of one or more APIs supplied by Nuvo.' No public API documentation, developer portal, SDK, or rate-limit details are provided on the main website. The API is described as an EMR connectivity feature for healthcare providers, not a public or partner-facing developer API.
What industry is Nuvo Group in?
Nuvo Group's product category is Remote Pregnancy Monitoring. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLACAPAG, Maternal, Neonatal & Pediatric Remote Monitoring. Its NAICS code is 339113 and its SIC code is 3841.